Looking forward to @asco later this week! Avoid the traffic when heading to the loop and take a shuttle or the Metra train which runs from inside McCormick to Millennium station. @ConquerCancerFd kindly sponsors a free digital Metra ticket

Looking forward to a great @ASCO Educational Session on utilizing artificial intelligence to accelerated oncology clinical trials with perspectives from FDA and FNIH on 5/30 430pm CST in S102, please join us for this pan-institutional discussion

Please join @DrAlexAdjei #DrRebeccaHeist and myself @ASCO on 5/30 630p CST at Sheraton Grand Chicago Riverwalk for a great discussion around MET targeted in NSCLC @gotoPER

Great to have new protein targeting ADCs (teliso-V for high MET in refractory NSCLC most recently), but one issue is we lack of liquid biopsy or multiplex platform for all the IHc targets we need (HER2, MET, PD-L1) and likely others upcoming. Multiplex/dig path solutions here.

Tuesday at #AACR25 looks to be action-packed with reports of progress on cell therapy in solid tumors! @pateloncology.bsky.social

Looking to be an outstanding @theaacr.bsky.social Clinical Trials Plenary session on Bispecifics and T cell engagers on Tues 4/29 10:15am CST featuring #wolchokj #hoperugo #jasonlukemd and other outstanding faculty. I am excited to be discussing CART in thyroid cancer in this great program

Thanks to @ASCO! I am grateful for this honor with these outstanding faculty and organization and look forward to seeing everyone in a few months in Chicago

Attention #OncologyFellows! Submit your #LungCancer essay by March 28 for a chance to join us in Chicago at #ASCO2025! This is an incredible opportunity to broaden your network, and gain invaluable experience. Don’t miss out—submit your essay www.surveymonkey.com/r/PS58XJ6 🚀

Honored to be joining LUNGevity’s Scientific Advisory Board to help support lung cancer research and patients

Great opportunity to share the stage with colleagues that have become friends at STS @pateloncology.bsky.social

🎥✨ Hear from @pateloncology.bsky.social as he shares a preview of our upcoming PeerView symposium at #STS2025! Join us in LA on 1/25 for expert discussions, interactive sessions, and cutting-edge insights. Don’t miss it—watch the teaser now! 👉 bit.ly/Immuno-LA-T #MedEd #Medsky #Oncsky

Do systemic responses to ICI (eg irAEs) associate w outcomes? Nice use of existing basket studies by @pateloncology.bsky.social @eladsharonmd.bsky.social Razelle Kurzrock et al

Had the pleasure of working JulieBrahmer and BrendonStiles with Medscape on a recent activity designed to help you learn more about IO in NSCLC.  www.medscape.org/viewarticle/...

@pateloncology.bsky.social on his approach to immunotherapy in patients with NSCLC